Microsoft word - kidney programme for www _2_.doc

Thursday 23 August

Evening - Novotel Lakeside - meet at the bar in the hotel. Nibbles and one drink will
be provided. Partners welcome. 6.00 – 7.00 pm. Registration open.

Friday 24 August

Welcome Rob Walker
CHAIR Priyakshi Kalita, University of Otago

7.30 – 8.30 am David Weiner, University of Florida, USA Membrane proteins

transport gasses: a new era in ammonia transport
8.30–8.45 am Bryna Chow, Tim Hewitson, Chrishan Samuel, University
Melbourne, Monash University, Royal Melbourne Hospital, Australia The role of relaxin and nitric oxide in the regulation of matrix metallo- proteinases in the kidney 8.45-9.00 am David Small, Yoann Royet, Glenda Gobe, University of Queensland,
Brisbane, Australia N-acetyl-cysteine attenuates oxidative stress-induced apoptosis in kidney proximal tubular epithelial cells
9.00 – 9.30 am Hans Peter Marti, University of Berne, Switzerland How to diagnose

and to prevent renal fibrosis in the future 4.30 pm – 7.00 pm FIBROSIS AND INFLAMMATION CHAIR Fay Khong, University of Melbourne

4.30 – 5.00 pm David Nikovic-Paterson, Monash University, Melbourne, Australia
Spleen tyrosine kinase (Syk) – a therapeutic target in antibody-dependent and
5.00 – 5.15 pm Priyakshi Kalita, Andrew Bahn, Rob Walker, John Leader, Jennifer
Bedford, University of Otago, New Zealand Mechanism underlying kidney fibrosis in rats due to prolonged lithium treatment
5.15 - 5.30 pm John Leader, Jennifer Bedford, Rob Walker University of Otago,
New Zealand Morphological changes in kidneys of rats after long term (six
5.30-5.45 pm Harshini Mudaliar, Steven Chadban, Huiling Wu, Carol Pollock, Usha
Panchapekesan University of Sydney, Royal North Shore Hospital, NSW, The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in human proximal tubular cells (PTC) 5.45 – 6.00 pm D Yaghobian, A Don, S Yaghobian, X-M Chen, S Saad, CA
Pollock Kolling Institute of Medicine Research, University of Sydney, Sydney, Australia; The Lowry Institute, University of New South Wales, Sydney, Australia The role of sphingosine 1-phosphate in the development of diabetic nephropathy 6.00 – 6.30 pm posters (both Friday and Saturday)
Horst Joachim Schirra, Shaffinaz Abd Rahman, Gary Leong, Michael J Waters
The University of Queensland, Australia; Mater Children's Hospital, Australia Of mice and men – NMR-based metabonomics from animal systems to M Davies, M Katerelos, SA Fraser, K Gleich, PF Mount, DA Power
Health, Melbourne, Australia; University of Melbourne, Australia The role of AMP-activated protein kinase (AMPK) in the regulation of NKCC1 AF Wise, TM Williams, J Zhuang, CS Samuel, SD Ricardo Monash
University, Australia The therapeutic potential of mesenchymal stem cells
Ingrid Fomison-Nurse, Yimmin Yao, Jeroen van der Sijde, Joanne C Harrison,
Gerard Davis, Ivan A Sammut University of Otago, New Zealand Renal fibrotic markers reduced by chronic bilateral renal denervation in experimental
Claudia Knake, Lisa Stamp, Andrew Bahn, University of Otago, Christchurch and
Dunedin, New Zealand Furosemide and alloprinol: an adverse drug interaction with clinical implications for treatment of gout in hypertensive
Metaneeya Pilanthananond, Cherie Stayner, Julia Horsfield, Michael Eccles
University of Otago, New Zealand Pathogenicity studies of a ciliopathy gene, 6.30 – 6.45 pm Fay Khong, Yuan Zhang, Amana J Edgley, Darren J Kelly
University of Melbourne, St Vincent’s Hospital Fitzroy, Melbourne, Australia The therapeutic potential of synthetic flavanols in the attenuation of kidney ischaemia and reperfusion: a valuable insight from an experimental model of
6.45 – 7.00 pm CR Tan, W Qi, Y Zhang, RG Langham, DJ Kelly St Vincent’s
Hospital, University of Melbourne, Australia TXNIP DNAzyme attenuates tubulointerstitial fibrosis in diabetic nephropathy Saturday 25 August

CHAIR Dania Yaghobian, University of Sydney
7.45 – 8.45 am Horst Joachim Schirra, Shaffinaz Adb Rahman, Juan Li, Gary
Leong, Michael J Wwaters, Gene WijffelsI, Paul R Ebert The University of Queensland, Brisbane, Queensland 4072, Australia; CSIRO Livestock Industries, 306 Carmody Road, St Lucia, Queensland 4067, Australia; Department of Paediatric Endocrinology and Diabetes, Mater Children's Hospital, South Brisbane, Queensland 4010, Australia A mammalian menagerie – an overview of NMR-based metabonomics from systems biology 8.45 – 9.15 am Kerry Loomes, University of Auckland, New Zealand Altered

metabolism of inositol sugars in streptozotocin-induced diabetes in rats due to 9.15 – 9.30 am Azrina Ralib, University of Otago, New Zealand Early increase in

plasma creatinine is common following significant renal hypoperfusion. 4.30 pm – 7.00 pm GENETICS AND DEVELOPMENT CHAIR Timothy Williams, Monash University

4.30 – 5.00 pm Sharon D Ricardo, Andrea F wise, Brooke M Huuskes, Christina V
Jones, Bi Song, Peter G Kerr, Chrishan S Samuel Monash University and Monash Medical Centre, Clayton, Victoria, Australia Cellular-based therapies for kidney repair and regeneration 5.00 – 5.15 pm VG Puelles, RN Douglas-Denton, J Li, MD Hughson, WE Hoy, JR
Nyengaard, JF Bertram Monash University, Melbourne, Australia; University of Mississippi Medical Center, Jackson, MS, USA; University of Queensland, Brisbane, Australia; Aarhus University Hospital, Aarhus, Denmark Podocyte depletion in obese Caucasian American men without renal disease 5.15 – 5.30 pm C Stayner, B Lett, L Slobbe, A Wiles, M Jennings1 D Markie, J
McEwan, AC Johnstone, RJ Walker, CA Poole, M Eccles University of
Otago, New Zealand; AgResearch Ltd., Invermay Research Centre, New
Zealand; Institute of Veterinary, Animal and Biomedical Sciences, New
Zealand Renal cystic disease: developing an ovine model
5.30 – 6.15 pm posters (Friday and Saturday)
Horst Joachim Schirra, Shaffinaz Abd Rahman, Gary Leong, Michael J Waters
The University of Queensland, Australia; Mater Children's Hospital, Australia Of mice and men – NMR-based metabonomics from animal systems to M Davies, M. Katerelos, SA Fraser, K Gleich, PF Mount, DA Power
Health, Melbourne, Australia; University of Melbourne, Australia The role of AMP-activated protein kinase (AMPK) in the regulation of NKCC1 AF Wise, TM Williams, J Zhuang, CS Samuel, SD Ricardo, Monash
University, Australia The therapeutic potential of mesenchymal stem cells
Ingrid Fomison-Nurse, Yimmin Yao, Jeroen van der Sijde, Joanne C. Harrison,
Gerard Davis, Ivan A Sammut University of Otago, New Zealand Renal fibrotic markers reduced by chronic bilateral renal denervation in experimental
Claudia Knake, Lisa Stamp, Andrew Bahn , University of Otago, Christchurch and
Dunedin, New Zealand Furosemide and alloprinol: an adverse drug interaction with clinical implications for treatment of gout in hypertensive
Metaneeya Pilanthananond, Cherie Stayner, Julia Horsfield, Michael Eccles
University of Otago, New Zealand Pathogenicity studies of a ciliopathy gene, 6.15 – 6.30 pm TM Williams, DS Layton, C. Samuela, JA Hamilton, SD Ricardo
Monash University, Melbourne, Australia; University of Melbourne, Royal Melbourne Hospital, Australia Tissue inflammation: a hallmark of kidney
6.30 – 6.45 pm M Eccles, C Stayner, J Shields, L Slobbe, J Shillingford, T
Weimbs University of Otago, New Zealand; University of California, Santa Barbara, California, USA Sirolimus can inhibit cyst growth in utero in Pkd1-/- mutant mice, but rodents are perhaps not the best model in which to study 6.45 – 7.00 pm CA Poole, C Stayner, SR McGlashan, K Parker, A Wiles, M Jennings,
CG Jensen, AC Johnstone, RJ Walker, MR Eccles University of Otago, New Zealand; University of Auckland, New Zealand; Massey University, New Zealand Primary cilia defects in the polycystic kidneys from an ovine model of Meckel Gruber

Source: http://www.qmb.org.nz/downloads/kidneyprogramme2012.pdf